We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

OPERON S.A.

Operon is engaged in the R&D and manufacturing of in vitro diagnostic products, including ready-to-use ELISA and mole... read more Featured Products: More products

Download Mobile App




Noninvasive Method Determines Subclinical Childhood Celiac Disease

By LabMedica International staff writers
Posted on 29 Mar 2016
A new, simple and noninvasive method has been developed to determine whether a child aged two to four years of age suffers from celiac disease (CD) or not, without the necessity of a blood extraction. More...
Silent celiac disease goes unnoticed to the eyes of the doctor because it presents minor symptoms, imperceptible even for the patient.

Celiac disease is a systemic disease caused by a permanent intolerance to gluten, which can be found in wheat, barley and rye, and it affects people with genetic predisposition. The symptoms are intestinal malabsorption, abdominal distension, diarrhea, abdominal pain, and extra-digestive including skin problems, joint pain, cephalalgia.

Scientists working in collaboration with those at the Virgen de las Nieves University Hospital (Granada, Spain) recruited 198 children aged two to four years, mean age 32.3 ± 9.2 months, and 53% were males. CD prevalence according to the serological tests was 3% (CI 95%, 1.4%–6.4%). Biopsies were used to confirm the diagnosis in all suspected cases. Cross-sectional study was carried in a sample population of children who were apparently healthy subjects from the same metropolitan area.

The team collected clinical, anthropometric, analytical, and serological variables. They also tested for anti-gliadin immunoglobulin A (IgA) and anti-transglutaminase IgG and IgA using a rapid immunochromatographic test CD1WB and CD2WB (Operon; Zaragoza, Spain). The tests detected six celiac children among the 198 who participated in the study, which is a very high prevalence of 3%, higher than the European mean. All of them presented no symptoms at all, or minor imperceptible symptoms which did not make their parents consult a pediatrician.

The sensitivity and negative predictive value of the CD2WB immunochromatographic test strip were 100% and 1, respectively. The sensitivity of CD1WB was 16.6% and its specificity was high at 89.1%. A positive outcome of the test will require further confirmation via blood extraction and assessment of the disease antibodies via other methods, but a negative outcome will allow the dismissal, with certainty, of being affected by the disease. The method does not require experienced personnel, although it has to be interpreted by health professionals, is quick as it only takes10 minutes, economic at EUR 10 to 12 per device, and, most important of all in the case of infant population, this method is less invasive than a blood extraction. The study was published originally published in September 2015 in the journal Pediatric Research.

Related Links:

Virgen de las Nieves University Hospital
Operon 



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.